CHYM stock forecast, quote, news & analysis
Chime Financial Inc is a financial technology company that provides digital banking services through its proprietary technology platform in partnership with third-party banks... Show more
Why Chime Financial (CHYM) Stock Is Up +28.5% in the Last 30 Days
Key Takeaways
- Chime Financial (CHYM) surged approximately 28.5% over the last 30 days, climbing from $16.70 on June 12 to $21.46 by July 14, 2026.
- The rally was fueled by Russell index inclusion, a bullish Barclays initiation, and sustained momentum from the company's first-ever GAAP-profitable quarter reported in May.
- Over the broader quarter, the stock staged a sharp recovery after hitting its 52-week low of $15.88 on June 11, powered by improving fundamentals and renewed institutional interest.
- Analyst consensus stands at Moderate Buy with an average 12-month price target near $29.65, implying roughly 38% upside from recent levels.
- Key risks include elevated competitive pressure in digital banking, insider selling activity, and ongoing GAAP net losses on a trailing-twelve-month basis despite quarterly profitability.
Chime Financial (CHYM) Company Overview and Market Position
Chime Financial, Inc. is a San Francisco-based financial technology company that provides mobile-first banking services designed to reduce fees and simplify everyday transactions. Founded in 2013, Chime operates a digital banking platform offering spending accounts, savings accounts, debit cards, and credit-building tools — all without monthly maintenance fees, overdraft charges, or foreign transaction fees. Revenue is primarily generated through interchange fees from debit and credit card transactions rather than customer charges.
Chime has grown to over 10.2 million active members as of Q1 2026 and was ranked the #1 financial institution for new checking account openings in the U.S. by J.D. Power. Its core products include the Chime Card (a secured credit product), MyPay (earned wage access), Instant Loans, and the recently launched Chime Prime premium membership tier. The company completed its IPO in June 2025 at $27 per share and trades on the Nasdaq under the ticker CHYM.
Chime Financial (CHYM) Stock Price Performance: Last 30 Days vs. Quarter
CHYM delivered a powerful 30-day rally, rising from a closing price of $16.70 on June 12, 2026, to $21.46 on July 14, 2026 — a gain of approximately 28.5%. The move was particularly notable given that the stock had hit its 52-week low of $15.88 just one day earlier on June 11, meaning the bounce off the bottom exceeded 35% from trough to the July 14 close.
The turning point arrived on June 26, when shares surged roughly 11% in a single session to $20.32 on more than double the average daily volume, as news of Chime's addition to multiple Russell indexes sparked institutional repositioning. Over the following weeks, CHYM consolidated gains in the $20.50–$21.50 range, supported by a constructive Barclays initiation and steady buying interest.
Looking at the broader quarter, CHYM's trajectory has been a tale of two halves. Through mid-June, the stock declined steadily from around $18–$19 in late May to its $15.88 low, pressured by broader fintech volatility and insider selling headlines. Since that bottom, however, shares have rebounded sharply, erasing all quarterly losses and turning modestly positive compared to late-April levels — driven by the fundamental story of accelerating revenue growth, margin expansion, and the achievement of GAAP profitability.
What Drove CHYM Stock Price in the Last 30 Days
The 30-day surge can be attributed to several concrete catalysts converging in a short window. First, Chime's inclusion in major Russell indexes — confirmed around June 26 — triggered significant buying from index-tracking funds and ETFs. The announcement drove the highest single-day volume in the stock's post-IPO history, with over 22 million shares traded on June 26 alone.
Second, on July 8, Barclays initiated coverage on Chime with an Overweight rating and a $26 price target, citing the company's durable franchise positioning and underappreciated monetization potential after the broader fintech sector reset. The initiation added to an already supportive analyst backdrop: of the 19 analysts covering CHYM, 14 rate it Buy or Strong Buy, with prominent firms including Morgan Stanley, Wells Fargo, and BMO Capital maintaining bullish outlooks.
Third, the market continued to digest the company's milestone Q1 2026 earnings reported on May 6. Chime posted its first GAAP-profitable quarter as a public company with net income of $53 million, revenue of $647 million (up 25% year-over-year), and adjusted EBITDA of $119 million (18% margin). Management raised full-year revenue guidance to $2.66–$2.69 billion and announced an additional $200 million share repurchase authorization, signaling confidence in sustained momentum.
Additional tailwinds included the launch of Chime Prime, a premium membership tier offering enhanced cash-back rewards and higher savings yields; accelerating adoption of the Chime Card secured credit product, which now accounts for roughly 25% of purchase volume; and rapid scaling of MyPay, which generated over $400 million in annualized revenue. Institutional accumulation also picked up, with HSBC Holdings disclosing a new position of approximately 49,866 shares in a recent 13F filing.
What Drove CHYM Stock Performance Over the Last Quarter
Over the past quarter, CHYM's performance reflects a broader narrative of transition from a post-IPO revaluation to a fundamentals-driven recovery. Earlier in the quarter, the stock faced headwinds from elevated short interest, insider selling — including two separate transactions by General Counsel Adam B. Frankel totaling 6,000 shares sold in June — and a broader risk-off sentiment affecting high-growth fintech names. Those pressures pushed shares to a 52-week low of $15.88.
The inflection came as investors began re-weighting Chime's improving unit economics against its discounted valuation. The Q1 earnings report demonstrated accelerating operating leverage: transaction margin expanded to 76%, incremental adjusted EBITDA margin reached 73%, and the proprietary ChimeCore processing platform began delivering measurable cost efficiencies. AI-assisted development now powers 84% of shipped code, enabling faster product velocity without proportional headcount growth. Combined with the Russell index catalyst, these fundamental improvements provided a credible floor for the stock and fueled the sharp recovery through July.
Trending AI Robots
For traders seeking data-driven approaches to navigating volatile stocks like Chime Financial, Tickeron's Trending AI Robots page offers a curated selection of top-performing algorithmic trading bots. While Tickeron operates hundreds of AI-powered bots across thousands of tickers, only those demonstrating consistent and relevant performance appear in this featured section. The bots span a range of strategies — from short-term momentum plays to longer-duration trend-following models — each with transparent performance metrics and trade histories. Exploring the Trending AI Robots page can help investors identify automated strategies aligned with their own trading style and risk tolerance.
CHYM Stock Forecast Drivers: What Investors Should Watch Next
The most immediate catalyst for CHYM is the upcoming Q2 2026 earnings report, expected around August 6, 2026. Management guided Q2 revenue between $633 million and $643 million with adjusted EBITDA margins of 11–12%, and investors will scrutinize whether the company can sustain its GAAP profitability streak for a second consecutive quarter.
Beyond earnings, key watchpoints include the pace of Chime Card adoption and its impact on take-rate expansion, the rollout of Chime Enterprise partnerships — including the forthcoming integration with First Student and its 65,000-plus employees — and continued MyPay and Instant Loans origination growth with stable loss rates. Macroeconomic factors, including consumer spending resilience, Federal Reserve policy direction, and interchange fee regulation debates, also remain relevant to Chime's revenue trajectory. With short interest at 4.33% of the float, any sustained upside could trigger additional short-covering activity.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CHYM sees MACD Histogram just turned negative
CHYM saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 23, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 7 instances where the indicator turned negative. In of the 7 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for CHYM moved out of overbought territory on July 20, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 2 similar instances where the indicator moved out of overbought territory. In of the 2 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 7 cases where CHYM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on July 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CHYM as a result. In of 17 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHYM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CHYM broke above its upper Bollinger Band on July 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
CHYM moved above its 50-day moving average on June 26, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CHYM crossed bullishly above the 50-day moving average on July 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHYM advanced for three days, in of 49 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 29 cases where CHYM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.470) is normal, around the industry mean (77.731). P/E Ratio (0.000) is within average values for comparable stocks, (76.057). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.525). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (3.419) is also within normal values, averaging (52.025).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CHYM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHYM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement